Cargando…

Resveratrol inhibits the phosphatidylinositide 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway in the human chronic myeloid leukemia K562 cell line

Resveratrol inhibits the initiation, promotion and progression of tumors, however, the mechanism by which resveratrol inhibits the proliferation of the human chronic myeloid leukemia K562 cell line remains unclear. The present study was conducted to investigate the effect of resveratrol on the activ...

Descripción completa

Detalles Bibliográficos
Autores principales:	SUI, TAO, MA, LI, BAI, XUE, LI, QING, XU, XINNV
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049760/ https://www.ncbi.nlm.nih.gov/pubmed/24932295 http://dx.doi.org/10.3892/ol.2014.2014

Ejemplares similares

Development and characterisation of a panel of phosphatidylinositide 3-kinase – mammalian target of rapamycin inhibitor resistant lung cancer cell lines
por: Heavey, Susan, et al.
Publicado: (2018)

Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas
por: Burrows, Natalie, et al.
Publicado: (2016)

Cell Signaling Associated with Na(+)/K(+)-ATPase: Activation of Phosphatidylinositide 3-Kinase IA/Akt by Ouabain Is Independent of Src
por: Wu, Jian, et al.
Publicado: (2013)

Impact of the Phosphatidylinositide 3-Kinase Signaling Pathway on the Cardioprotection Induced by Intermittent Hypoxia
por: Milano, Giuseppina, et al.
Publicado: (2013)

The phosphatidylinositide 3-kinase (PI3K) signaling pathway is a determinant of zileuton response in adults with asthma
por: Dahlin, Amber, et al.
Publicado: (2018)

Targeting Phosphatidylinositide3-Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinoma
por: Liu, Wei-Lin, et al.
Publicado: (2014)

Selective binding of a toxin and phosphatidylinositides to a mammalian potassium channel
por: Liu, Yang, et al.
Publicado: (2019)

Tuberous sclerosis complex tumor suppressor–mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent
por: Jaeschke, Anja, et al.
Publicado: (2002)

Proliferation-Attenuating and Apoptosis-Inducing Effects of Tryptanthrin on Human Chronic Myeloid Leukemia K562 Cell Line in Vitro
por: Miao, Shan, et al.
Publicado: (2011)

Phosphatidylinositide 3-Kinase Contributes to the Anti-Inflammatory Effect of Abutilon crispum L. Medik Methanol Extract
por: Hunto, Stephanie Triseptya, et al.
Publicado: (2018)

Vitamin E TPGS 1000 Induces Apoptosis in the K562 Cell Line: Implications for Chronic Myeloid Leukemia
por: Calvo-Alvarez, Jazmin, et al.
Publicado: (2021)

Resveratrol Inhibits Cancer Cell Metabolism by Down Regulating Pyruvate Kinase M2 via Inhibition of Mammalian Target of Rapamycin
por: Iqbal, Mohd Askandar, et al.
Publicado: (2012)

Antiproliferative Effect of Aaptamine on Human Chronic Myeloid Leukemia K562 Cells
por: Jin, Meihua, et al.
Publicado: (2011)

Anticancer activity of Pupalia lappacea on chronic myeloid leukemia K562 cells
por: Ravi, Alvala, et al.
Publicado: (2012)

Tendency of K562 Chronic Myeloid Leukemia Cells Towards Cell Reprogramming
por: Yılmazer Aktuna, Açelya
Publicado: (2018)

The Effect of Polyhydroxy Fullerene Derivative on Human Myeloid Leukemia K562 Cells
por: Guo, Wei, et al.
Publicado: (2022)

Checkpoint kinase-1 inhibition and etoposide exhibit a strong synergistic anticancer effect on chronic myeloid leukemia cell line K562 by impairing homologous recombination DNA damage repair
por: Fan, Zhuoyi, et al.
Publicado: (2020)

Inhibition of mammalian S6 kinase by resveratrol suppresses autophagy
por: Armour, Sean M., et al.
Publicado: (2009)

Rapamycin enhanced the antitumor effects of doxorubicin in myelogenous leukemia K562 cells by downregulating the mTOR/p70S6K pathway
por: Li, Jie, et al.
Publicado: (2019)

Inhibition of abl Oncogene Tyrosine Kinase Induces Erythroid Differentiation of Human Myelogenous Leukemia K562 Cells
por: Honma, Yoshio, et al.
Publicado: (1990)

Cytotoxicity of Isoxazole Curcumin Analogs on Chronic Myeloid Leukemia-Derived K562 Cell Lines Sensitive and Resistant to Imatinib
por: Feriotto, Giordana, et al.
Publicado: (2023)

Transforming somatic mutations of mammalian target of rapamycin kinase in human cancer
por: Yamaguchi, Hiroyuki, et al.
Publicado: (2015)

Intracellular Localization of Phosphatidylinositide 3-kinase and Insulin Receptor Substrate-1 in Adipocytes: Potential Involvement of a Membrane Skeleton
por: Clark, Sharon F., et al.
Publicado: (1998)

GATA‐1 isoforms differently contribute to the production and compartmentation of reactive oxygen species in the myeloid leukemia cell line K562
por: Riccio, Patrizia, et al.
Publicado: (2019)

Combining the mammalian target of rapamycin inhibitor, rapamycin, with resveratrol has a synergistic effect in multiple myeloma
por: Jin, Hong-Guang, et al.
Publicado: (2018)

Induction of human chronic myeloid leukemia K562 cell apoptosis by virosecurinine and its molecular mechanism
por: ZHANG, GANG, et al.
Publicado: (2014)

CDA gene silencing regulated the proliferation and apoptosis of chronic myeloid leukemia K562 cells
por: Wei, Xiao-Fang, et al.
Publicado: (2018)

Mechanism for the synergistic effect of rapamycin and resveratrol on hyperinsulinemia may involve the activation of protein kinase B
por: Chen, J, et al.
Publicado: (2013)

Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors
por: Wanigasooriya, Kasun, et al.
Publicado: (2020)

HPV8-E6 Interferes with Syntenin-2 Expression through Deregulation of Differentiation, Methylation and Phosphatidylinositide-Kinase Dependent Mechanisms
por: Marx, Benjamin, et al.
Publicado: (2017)

The miR-203a Regulatory Network Affects the Proliferation of Chronic Myeloid Leukemia K562 Cells
por: He, Jinhua, et al.
Publicado: (2021)

PTEN and rapamycin inhibiting the growth of K562 cells through regulating mTOR signaling pathway
por: Cheng, Zhi Y, et al.
Publicado: (2008)

Time-series analysis in imatinib-resistant chronic myeloid leukemia K562-cells under different drug treatments
por: Zhao, Yan-hong, et al.
Publicado: (2017)

Growth inhibitory effects of crude pomegranate peel extract on chronic myeloid leukemia, K562 cells
por: Asmaa, Mat Jusoh Siti, et al.
Publicado: (2015)

Cytotoxic effect of sea anemone pore-forming toxin on K562 chronic myeloid leukemia cells
por: Abdoli, Vali, et al.
Publicado: (2021)

Can phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibition ERase them all?
por: Meyer, Dominique S, et al.
Publicado: (2010)

The mammalian target of rapamycin (mTOR) kinase mediates haloperidol-induced cataleptic behavior
por: Ramírez-Jarquín, Uri Nimrod, et al.
Publicado: (2020)

MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1
por: Zhou, MinRan, et al.
Publicado: (2013)

Cytotoxic Effects of Some Flavonoids and Imatinib on the K562 Chronic Myeloid Leukemia Cell Line: Data Analysis Using the Combination Index Method
por: Danışman Kalındemirtaş, Ferdane, et al.
Publicado: (2019)

Synergistic anticancer effects of everolimus (RAD001) and Rhein on gastric cancer cells via phosphoinositide-3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway
por: Gao, Feng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lhhis6p3q360dnakjbij5qv682